LATHAM, N.Y.--(BUSINESS WIRE)--Dec. 20, 2018--
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative,
minimally invasive medical devices for vascular access, peripheral
vascular disease, and oncology, today announced that Jim Clemmer,
President and Chief Executive Officer, and Michael C. Greiner, Executive
Vice President and Chief Financial Officer, will present at the 37th
Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Tuesday,
January 8, 2019 in San Francisco, CA.
A live webcast of the presentation and Q&A breakout session will be
accessible through the “Investors” section of the Company’s website at www.angiodynamics.com
and will be available for replay following the event.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, peripheral vascular disease, and oncology.
AngioDynamics’ diverse product lines include market-leading ablation
systems, fluid management systems, vascular access products,
angiographic products and accessories drainage products, thrombolytic
products and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181220005716/en/
Source: AngioDynamics, Inc.
Investor Contact:
AngioDynamics, Inc.
Michael C. Greiner,
Executive Vice President & CFO
(518) 795-1821